In vitro, compound 17 (Figure 5A, compound 6b, IC50LSD1 = 0.65 μM) [63] was found to be a better inhibitor in this series of compounds and showed strong cytotoxicity against gastric cancer cells with LSD1 overexpression. This evidence concerns the gene KDM1A and gastric cancer.